Drug Type Bispecific antibody |
Synonyms- |
Target |
Action inhibitors |
Mechanism IL-1α inhibitors(Interleukin-1 alpha inhibitors), IL-1β inhibitors(Interleukin-1 beta inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Endometriosis | Phase 1 | China | 16 Apr 2026 | |
| Hidradenitis Suppurativa | Phase 1 | China | 16 Apr 2026 | |
| Uveitis | IND Application | China | 24 Mar 2026 | |
| Non-infectious posterior uveitis | Preclinical | China | 16 Jan 2026 |






